AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 203.88 +0.14 (+0.07%)MSFT 123.45 +0.4 (+0.33%)FB 178.27 +0.03 (+0.02%)ZNGA 5.44 +0.09 (+1.59%)NVDA 186.25 +0.19 (+0.10%)WBA 54.62 -0.33 (-0.60%)GOOG 1237.48 -0.16 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ANIK Quote Anika Thera

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 104 133 89
ShortTermInvest 20 24 70
Cash 125 157 159
AccountReceivab 28 24 21
Inventories 16 22 21
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 170 206 203
PPE 79 76 78
AccumulatedDepr -27 -20 -24
NetPPE 52 56 54
EquityAndOtherI 0 0 0
Goodwill 7 8 8
IntangibleAsset 10 11 9
OtherLTAssets 0 1 5
TotalNonCurrent 70 76 76
TotalAssets 240 283 279
ShortTermDebt 0 0 0
AccountsPayable 2 7 3
TaxesPayable 0 0 0
AccruedLiabilit 3 3 8
DeferredRevenue 0 0 0
OtherCurrentLia 3 3 0
TotalCurrentLia 9 13 11
Debt 0 0 0
DeferredTaxesLi 7 5 4
DeferredRevenue 0 0 0
OtherLTLiabilit 2 1 1
TotalNonCurrent 9 6 4
TotalLiabilitie 17 19 15
CommonStock 0 0 0
AdditionalPaidI 62 69 51
RetainedEarning 168 200 218
AccumulatedOthe -7 -5 -6
TotalStockholde 223 263 264
TotalLiabilitie 240 283 279
Anika Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Anika Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.